Il y a eu 50 transactions d'initiés récentes enregistrées pour Compass Therapeutics, Inc. (CMPX), dont 35 achats et 11 ventes. Le total des achats d'initiés s'élève à $40.34M et le total des ventes d'initiés à $12.64M.
Les initiés notables ayant une activité récente comprennent Schuetz Thomas J., Lindahl Richard S, Gray Mary Ann. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.
Transactions d'Initiés — CMPX
| Date |
Nom |
Rôle |
Type de Transaction |
Actions |
Prix Moyen |
Valeur |
Actions détenues |
| 2026-02-08 |
Schuetz Thomas J. |
Chief Executive Officer |
Retenue Fiscale RSU |
36,687 |
$6.52 |
$239.2K |
6,603,336 |
| 2026-01-09 |
Schuetz Thomas J. |
Chief Executive Officer |
Retenue Fiscale RSU |
46,777 |
$5.35 |
$250.26K |
6,640,023 |
| 2026-01-02 |
Lindahl Richard S |
Director |
Attribution de RSU |
90,000 |
$5.17 |
$465.3K |
90,000 |
| 2026-01-02 |
Gray Mary Ann |
Director |
Attribution de RSU |
90,000 |
$5.17 |
$465.3K |
90,000 |
| 2026-01-02 |
Gordon Carl L |
Director |
Attribution de RSU |
90,000 |
$5.17 |
$465.3K |
90,000 |
| 2026-01-02 |
Chiniara Ellen |
Director |
Attribution de RSU |
90,000 |
$5.17 |
$465.3K |
90,000 |
| 2026-01-02 |
Lerner Neil |
Chief Accounting Officer |
Attribution de RSU |
62,500 |
$5.17 |
$323.13K |
382,500 |
| 2026-01-02 |
Schuetz Thomas J. |
CEO |
Attribution de RSU |
2,000,000 |
$5.17 |
$10.34M |
2,000,000 |
| 2026-01-02 |
Shin Barry |
CFO |
Attribution de RSU |
125,000 |
$5.17 |
$646.25K |
525,000 |
| 2026-01-02 |
Sirard Cynthia |
Officer |
Inconnu |
- |
- |
- |
- |
| 2026-01-02 |
Sirard Cynthia |
Chief Medical Officer |
Attribution de RSU |
1,000,000 |
$5.17 |
$5.17M |
1,000,000 |
| 2026-01-02 |
Ferneau Philip |
Director |
Attribution de RSU |
90,000 |
$5.17 |
$465.3K |
90,000 |
| 2026-01-02 |
Boylan James P |
Director |
Attribution de RSU |
90,000 |
$5.17 |
$465.3K |
90,000 |
| 2026-01-02 |
Anderman Jonathan |
General Counsel |
Attribution de RSU |
150,000 |
$5.17 |
$775.5K |
171,000 |
| 2026-01-02 |
Prasad Arjun |
Officer |
Inconnu |
- |
- |
- |
- |
| 2026-01-02 |
Prasad Arjun |
Chief Commercial Officer |
Attribution de RSU |
1,000,000 |
$5.17 |
$5.17M |
1,000,000 |
| 2025-11-16 |
Schuetz Thomas J. |
Chief Executive Officer |
Retenue Fiscale RSU |
44,025 |
$4.83 |
$212.64K |
6,436,800 |
| 2025-05-27 |
Schuetz Thomas J. |
Chief Executive Officer |
Achat Informatif |
10,000 |
$2.11 |
$21.1K |
6,480,825 |
| 2025-04-09 |
Orbimed Advisors Llc |
10 Percent Owner |
Vente Informative |
3,571,428 |
$1.59 |
$5.68M |
- |
| 2025-04-09 |
Gordon Carl L |
10 Percent Owner |
Vente Informative |
3,571,428 |
$1.59 |
$5.68M |
- |
| 2025-04-07 |
Lerner Neil |
Chief Accounting Officer |
Achat Informatif |
20,000 |
$1.42 |
$28.4K |
320,000 |
| 2025-04-07 |
Anderman Jonathan |
Gen Counsel & Corporate Sec |
Achat Informatif |
20,000 |
$1.54 |
$30.8K |
21,000 |
| 2025-02-11 |
Lindahl Richard S |
Director |
Attribution de RSU |
40,000 |
$3.65 |
$146K |
40,000 |
| 2025-02-11 |
Gray Mary Ann |
Director |
Attribution de RSU |
40,000 |
$3.65 |
$146K |
40,000 |
| 2025-02-11 |
Gordon Carl L |
10 Percent Owner |
Attribution de RSU |
40,000 |
$3.65 |
$146K |
40,000 |
| 2025-02-11 |
Chiniara Ellen |
Director |
Attribution de RSU |
40,000 |
$3.65 |
$146K |
40,000 |
| 2025-02-11 |
Lerner Neil |
SVP, CAO |
Attribution de RSU |
200,000 |
$3.65 |
$730K |
200,000 |
| 2025-02-11 |
Schuetz Thomas J. |
Chief Executive Officer |
Attribution de RSU |
1,500,000 |
$3.65 |
$5.48M |
1,500,000 |
| 2025-02-11 |
Shin Barry |
CFO |
Attribution de RSU |
250,000 |
$3.65 |
$912.5K |
250,000 |
| 2025-02-11 |
Ferneau Philip |
Director |
Attribution de RSU |
40,000 |
$3.65 |
$146K |
40,000 |
| 2025-02-11 |
Boylan James P |
Director |
Attribution de RSU |
40,000 |
$3.65 |
$146K |
40,000 |
| 2025-02-11 |
Anderman Jonathan |
Sr VP, Gen Counsel & Corp Sec |
Attribution de RSU |
280,000 |
$3.65 |
$1.02M |
280,000 |
| 2025-02-08 |
Schuetz Thomas J. |
CEO |
Retenue Fiscale RSU |
41,687 |
$3.50 |
$145.9K |
6,470,825 |
| 2025-01-09 |
Schuetz Thomas J. |
CEO |
Retenue Fiscale RSU |
58,054 |
$1.86 |
$107.98K |
6,512,512 |
| 2024-12-09 |
Lerner Neil |
VP Finance |
Inconnu |
175,000 |
$1.20 |
$210K |
- |
| 2024-12-09 |
Shin Barry |
Officer |
Inconnu |
- |
- |
- |
- |
| 2024-12-09 |
Shin Barry |
CFO |
Attribution de RSU |
400,000 |
$1.65 |
$660K |
400,000 |
| 2024-08-13 |
Anderman Jonathan |
Sr VP, Gen Counsel & Corp Sec |
Attribution de RSU |
300,000 |
$1.20 |
$360K |
300,000 |
| 2024-08-01 |
Anderman Jonathan |
Sr VP, Gen Counsel & Corp Sec |
Cession |
80,000 |
$1.57 |
$125.6K |
- |
| 2024-03-08 |
Boylan James P |
Director |
Attribution de RSU |
40,000 |
$1.96 |
$78.4K |
40,000 |
| 2024-02-09 |
Lindahl Richard S |
Director |
Attribution de RSU |
40,000 |
$1.57 |
$62.8K |
40,000 |
| 2024-02-09 |
Gray Mary Ann |
Director |
Attribution de RSU |
40,000 |
$1.57 |
$62.8K |
40,000 |
| 2024-02-09 |
Gordon Carl L |
10 Percent Owner |
Attribution de RSU |
40,000 |
$1.57 |
$62.8K |
40,000 |
| 2024-02-09 |
Chiniara Ellen |
Director |
Attribution de RSU |
40,000 |
$1.57 |
$62.8K |
40,000 |
| 2024-02-09 |
Ferneau Philip |
Director |
Attribution de RSU |
40,000 |
$1.57 |
$62.8K |
40,000 |
| 2024-02-08 |
Schuetz Thomas J. |
President |
Retenue Fiscale RSU |
44,782 |
$1.45 |
$64.93K |
6,570,566 |
| 2024-02-08 |
Bisker-leib Vered |
Chief Executive Officer |
Retenue Fiscale RSU |
49,198 |
$1.45 |
$71.34K |
3,124,426 |
| 2024-01-09 |
Schuetz Thomas J. |
President of R&d |
Attribution de RSU |
637,500 |
$1.93 |
$1.23M |
637,500 |
| 2024-01-09 |
Bisker-leib Vered |
Chief Executive Officer |
Attribution de RSU |
1,753,125 |
$1.93 |
$3.38M |
1,753,125 |
| 2023-11-17 |
Schuetz Thomas J. |
Chief Executive Officer |
Retenue Fiscale RSU |
44,025 |
$1.50 |
$66.04K |
5,977,848 |
■ Informatif — transaction sur marché ouvert (la plus significative)
■ Non informatif (achat) — récompense, exercice d'option, conversion
■ Non informatif (vente) — retenue fiscale, vente à l'acquisition
■ Neutre — don, fiducie, expiration
Les autres consultent aussi
